PEAK6 Investments
Edit

PEAK6 Investments

https://www.peak6.com
Last activity: 09.04.2025
Active
We're In The Business Of What Ought To Be.
Likes
604
Portfolio
3
Mentions
20
Location: United States, Kansas, Overland Park
Employees: 1001-5000
Phone:+1 312-444-8000
Founded date: 1997
Investment Type: Venture Capital
Investment Stage: Series B

Portfolio 3

DateNameWebsiteTotal RaisedLocation
13.04.2023Tradiertradier.com$27.7MHaiti, L'A...
31.01.2023Colossal B...colossal.com$485MUnited Sta...
25.10.2021Thrasiothras.io$2.89BUnited Sta...

Mentions in press and media 20

DateTitleDescription
09.04.2025One of America’s richest self-made women urges entrepreneurs to see volatile stock markets as an ‘opportunity’Americans have been on edge this week as the stock market reacted to new tariffs from the Trump administration announced on April 2 and in effect Wednesday. It’s made an “always challenging” environment for founders and investors of small a...
16.01.2025The Dawn of De-Extinction: Colossal Biosciences Rises to New HeightsIn a world where extinction looms like a dark cloud, a beacon of hope has emerged. Colossal Biosciences, a Dallas-based startup, is rewriting the rules of biology. With a recent $200 million Series C funding round, the company has soared to...
16.01.2025Colossal: $200 Million (Series C) Raised At $10.2 Billion Valuation For De-Extinction TechnologyDe-extinction company Colossal Biosciences announced $200 million in a Series C funding round by TWG Global, jointly led by Mark Walter and Thomas Tull. And Colossal’s additional strategic investors include funds such as USIT, Animal Capita...
15.01.2025De-Extinction Startup Colossal Biosciences Hits Decacorn Status After $200M Raise4 Shares Email Facebook Twitter LinkedIn Colossal Biosciences, a de-extinction startup looking at ways to bring back the dodo bird and the woolly mammoth, raised a $200 million Series C at a $10.2 billion valuation. The new cash infusion ca...
15.01.2025Colossal Raises $200M in Series C FundingColossal Biosciences, a Dallas, TX-based de-extinction company, raised $200M in Series C Funding. Backers included TWG Global. Other investors included USIT, Animal Capital, Breyer Capital, At One Ventures, In-Q-Tel, BOLD Capital, Peak 6, D...
10.12.2024Cala Health's $50 Million Surge: A New Dawn for Tremor TherapyCala Health is making waves. The California-based company has just secured $50 million in a growth funding round. This isn't just a financial boost; it's a lifeline for those grappling with essential tremor. Cala Health specializes in bioel...
09.12.2024Cala Health Closes $50M FinancingCala Health, a San Mateo, CA-based non-invasive bioelectronic medicine company, raised $50M in funding. The round was led by Vertex Growth Fund and Nexus NeuroTech Ventures. Existing investors participated in the round, including Action Pot...
09.12.2024Cala Health Raises $50M for Wearable Tremor TreatmentWhat You Should Know: – Cala Health, the non-invasive bioelectronic medicine leader, today announced it has raised a $50 million growth round, co-led by Vertex Growth Fund and Nexus NeuroTech Ventures. – All existing Cala investors particip...
09.12.2024Cala Health: Bioelectronic Medicine Leader Raises $50 Million (Growth Round)Cala Health – a non-invasive bioelectronic medicine leader – announced it has raised the initial closing of an oversubscribed $50 million growth round, co-led by Vertex Growth Fund and Nexus NeuroTech Ventures. And all existing Cala investo...
29.08.2024The AI Gold Rush: Investment and Infrastructure Shaping TomorrowThe world is in the midst of an AI gold rush. Companies are scrambling to stake their claims in this burgeoning landscape. Two recent developments highlight this trend: Magnetar’s $235 million AI fund and CoreWeave’s partnership with EcoDat...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In